Roche to buy Telavant for $7.1 billion



Roche announced on Monday that it reached a definitive agreement to buy Telavant Holdings, Inc. from Roivant Sciences Ltd. and Pfizer Inc. for $7.1 billion. Besides the purchase price, which will be p…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento